Man Group PLC Uni Qure N.V. Transaction History

Man Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $348,574 - $525,554	19,237 New	19,237 $436,000
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $3.94 Million - $5.22 Million	-109,520 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $4.55 Million - $6.84 Million	100,961 Added 1179.59%	109,520 $4.94 Million
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $342,445 - $633,109	8,559 New	8,559 $406,000
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $1.64 Million - $2.55 Million	-31,004 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $849,199 - $2.12 Million	31,004 New	31,004 $1.85 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.